Major Medical Device
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
2010 Commonwealth Games ~ 2010 Nobel Prizes ~ Sachin Tendulkar ~ Rajasthan Royals ~ Kings XI Punjab ~ Sushil Kumar ~ Deepika Kumari ~ Somdev Devvarman ~ HR Bhardwaj
Home / India News / 2007 / March / March 22, 2007
Major Medical Device Manufacturers See Treatment of Peripheral Vascular Diseases as Major Revenue Growth Generator

Top News

144 Section in Hyderabad ahead of Ayodhya verdict

Manmohan Singh to campaign in Bihar today

FBI failed to act on Headley's wife's terror link expose 3 yrs before Mumbai attacks

Craven's horror flicks 'were inspired by real stories'

RBI will intervene if inflows turn lumpy: Subbarao

Enforcement Directorate issues 'Look Out Circular' against Lalit Modi

Now, laser technology that destroys tumours using heat

Waist size, not BMI can foretell cardiovascular risk in children

Major Medical Device Manufacturers See Treatment of Peripheral Vascular Diseases as Major Revenue Growth Generator

Mumbai, Maharashtra, India

Stenting and stent graft procedures are now transitioning into the gold standard form of treatment for combating peripheral vascular diseases (PVD). An underserved market with high rates of disability and morbidity, PVD represents a significant market opportunity for medical stent manufacturers. Since the industry requires specialized devices to address the vast intricacies of the peripheral vasculature, market participants have the prospect to utilize their versatile expertise in design and development. The stellar clinical success and titanic revenue streams generated by the coronary stent market have sparked significant interest in their sister devices.

Frost & Sullivan (http://www.medicaldevices.frost.com) finds that U.S. Peripheral Stent and Stent Graft Market earned revenues of $ 855.8 million in 2005 and estimates this to reach $1,153 million in 2012

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the U.S. Peripheral Stent and Stent Graft Market, then send an e-mail to Melina Trevino, Corporate Communications, at melina.Trevino@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

"As the debilitating consequences to untreated peripheral vascular diseases mounts, there will be an increased pressure for clinically superior preventative medical device technologies," notes Frost & Sullivan Research Analyst Venkat Rajan

Increased awareness and reimbursement for screening procedures to identify at risk patients for peripheral vascular diseases, coupled with the evolution of advanced minimally invasive surgical procedures are poised to lead to significant growth in the number of peripheral stent and stent graft procedures.

Peripheral vascular diseases such as abdominal aortic aneurysms, and lower limb occlusions are slow developing and for the most part go unnoticed by patients. Abdominal aortic ruptures are known as the silent killer, since they occur with little to no pre warning and are for the most part fatal. Other peripheral occlusions are accompanied by pain and numbness, but are often dismissed by patients as the simple signs of aging. Due to the lack of awareness the patients who would most benefit from medical device therapy, often fail to receive timely treatment.

"Furthermore, for patient who are identified with a peripheral occlusion there are a number of whom are not qualified for a stent due to their anatomy and the size of the occlusion. Due to risk of stent migration, fracture rates, and endovascular leakage stent-grafts are only applicable to less then half of the potential patient population. Advancement in technology and refinement of procedures are necessary to expand device usage", says Rajan.

The development of next generation solutions that offer significant improvements over the current line of devices available on the market will serve a great deal in improving device usage. Improvements to device flexibility and durability, along with the capacity to address the immense anatomical range of occlusions are necessary for the industry to move forward.

U.S. Peripheral Stent and Stent Grafts Market is part of the Medical Devices subscription, which also includes research in the following markets: the U.S. Carotid and Intracranial Devices, the U.S. Angioplasty and Vascular Closure Devices Market, and the U.S. Atherectomy and Thrombectomy Devices market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews are available to the press.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.frost.com.

U.S. Peripheral Stent and Stent Grafts Market
F842-54

Shwetha Thomas, Corporate Communications - South Asia & Middle East, Frost & Sullivan, + 91 (022) 4001 3429 sthomas@frost.com

Melina Trevino, Corporate Communications - North America, Frost & Sullivan, + 1 210 247 2440 melina.trevino@frost.com

Source: Frost & Sullivan (Business Wire India)

Press release presented here is sourced from the Source mentioned above and is provided on as-is basis. Please contact the Company / Source directly for any further information in regard to this release. This website will be unable to assist you in regard to the accuracy or correctness of information in this release.

India News / Press Releases on March 22, 2007

Radhika Shapoorjee Moves to IPAN
Business Wire India

Thermal Power Capacity Additions Expand Opportunities in the Australia and New Zealand (ANZ) Power Plant Services Markets
Business Wire India

Metro Ethernet's Suitability for Bandwidth-Intensive Applications, Bolsters its Adoption in North America
Business Wire India

Major Medical Device Manufacturers See Treatment of Peripheral Vascular Diseases as Major Revenue Growth Generator
Business Wire India

Wipro BPO Sweeps IQPC's 2007 Global Excellence Awards
Business Wire India

INC Research Launches Operations in India
Business Wire India

Also see International News / Press Releases on March 22, 2007

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us